Role of Na+/H+ exchanger in acetylcholine-mediated pulmonary artery contraction of Spontaneously hypertensive rats

European Journal of Pharmacology

Volumn 464, Issue 2-3, 2003, Pages 177-187

  Chau, Wing Han ^a   Lee, Wai Hung ^a   Lau, Wing Hung ^b   Kwan, Yiu Wa ^a   Au, Alice Lai Shan ^b   Raymond, Kenneth ^a  

^a Prince of Wales Hospital   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Acetylcholine; Na+ H+ exchanger; Pulmonary artery; Rat (SHR); Rat (WKY); Spontaneously hypertensive; Wistar Kyoto

Indexed keywords

1 [2 (4 METHOXYPHENYL) 2 [3 (4 METHOXYPHENYL)PROPOXY]ETHYL] 1H IMIDAZOLE; 2 [2 [4 (4 NITROBENZYLOXY)PHENYL]ETHYL]ISOTHIOUREA METHANESULFONATE; 2,4 DICHLOROBENZAMIL; 4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; 5 (N ETHYL N ISOPROPYL)AMILORIDE; ACETYLCHOLINE; AMILORIDE; BENZAMIL; CALCIUM ION; CHOLINE; CHOLINESTERASE INHIBITOR; MEGLUMINE; MUSCARINIC M3 RECEPTOR; MUSCARINIC M3 RECEPTOR ANTAGONIST; NEOSTIGMINE; SODIUM ION; SODIUM PROTON EXCHANGE PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; RAT; SMOOTH MUSCLE FIBER; SODIUM TRANSPORT; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0037454119     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)01424-9     Document Type: Article

References (60)

1. Adegunloye B.J., Sofola O.A. Effect of dietary salt loading and high-calcium diet on vascular smooth muscle responses and endothelium function in rats. Clin. Exp. Pharmacol. Physiol. 24:1997;814-818.
2. Aharinejad S., Schraufnagel D.E., Bock P., MacKay C.A., Larson E.K., Miksovsky A., Marks S.C. Jr. Spontaneously hypertensive rats develop pulmonary hypertension and hypertrophy of pulmonary venous sphincters. Am. J. Pathol. 148:1996;281-290.
3. Altiere R.J., Travis D.C., Roberts J., Thompson D.C. Pharmacological characterization of muscarinic receptors mediating acetylcholine-induced contraction and relaxation in rabbit intrapulmonary arteries. J. Pharmacol. Exp. Ther. 270:1994;269-276.
4. 2+ release from the sarcoplasmic reticulum in the arterioles of spontaneous hypertensive rats. Am. J. Hypertens. 12:1999;1236-1242.
5. 2+ signaling in arterial myocytes. Am. J. Physiol. 278:2000;C163-C173.
6. Arunlakshana O., Schild H.O. Some quantitative uses of drug antagonists. Br. J. Pharmacol. 14:1959;48-58.
7. + exchange. J. Clin. Invest. 83:1989;822-829.
8. Bradley D.E., McNary W.F., Bermani E.L. The distribution of acetylcholinesterase and catecholamine containing nerves in the rat lung. Anat. Rec. 167:1970;205-207.
9. Buckley N.J., Bonner T.I., Buckley C.M., Brann M.R. Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. Mol. Pharmacol. 35:1989;469-476.
10. + exchanger. Cardiovasc. Res. 53:2002;862-868.
11. Choy W.Y., Wong Y.F., Kwan Y.W., Au A.L.S., Lau W.H., Raymond K., Zuo J.Z. Role of mitogen-activated protein kinase pathway in acetylcholine-mediated in vitro relaxation of rat pulmonary artery. Eur. J. Pharmacol. 434:2002;55-64.
12. De Michele M., Cavallotti C., Amenta F. Autoradiographic localization of muscarinic acetylcholine receptors in the rat pulmonary vascular tree. Eur. J. Pharmacol. 192:1991;71-78.
13. Dinh Xuan A.T., Higenbottam T.W., Clelland C., Pepke-Zaba J., Cremona G., Wallwork J. Impairment of pulmonary endothelium-dependent relaxation in patients with Eisenmenger's syndrome. Br. J. Pharmacol. 99:1989;9-10.
14. Dörje F., Wess J., Lambrecht G., Tacke R., Mutschler E., Brann M.R. Antagonist binding profiles of five cloned human muscarinic receptor subtypes. J. Pharmacol. Exp. Ther. 256:1991;727-733.
15. Duckles S.P. Vascular muscarinic receptors: pharmacological characterization in the bovine coronary artery. J. Pharmacol. Exp. Ther. 246:1988;929-934.
16. Egan B.M., Petrin J., Hoffmann R.G. NaCl induces differential changes of regional vascular reactivity in salt-sensitive versus salt-resistant men. Am. J. Hypertens. 4:1991;924-931.
17. Eglen R.M., Michel A.D., Montgomery W.W., Kunysz E.A., Machado C.A., Whiting R.L. The interaction of para-fluorohexahydrosiladifenidol at muscarinic receptors in vitro. Br. J. Pharmacol. 99:1990;637-642.
18. Eglen R.M., Choppin A., Watson N. Therapeutics opportunities from muscarinic receptor research. TIPS. 22:2001;409-414.
19. El-Kashef H.A., Catravas J.D. The nature of muscarinic receptors subtypes mediating pulmonary vasoconstriction in the rabbit. Pulm. Pharmacol. 4:1991;8-19.
20. El-Kashef H.A., Hofman W.F., Ehrhart I.C., Catravas J.D. Multiple muscarinic receptor subtypes in the canine pulmonary circulation. J. Appl. Physiol. 71:1991;2032-2043.
21. Fasolato C., Pizzo P., Pozzan T. Receptor-mediated calcium influx in PC12 cells. ATP and bradykinin activate two independent pathways. J. Biol. Chem. 265:1990;20351-20355.
22. Fronhoffs S., Mengden T., Oliveira J., Sachinidis A., Vetter H. Cholesterol enhances contractile responses in isolated small mesenteric arteries of normotensive and spontaneously hypertensive rats. J. Hypertens. 17:1999;1941-1947.
23. 2+ mobilization in the rat aortic smooth muscle cell line A7r5. Exp. Physiol. 77:1992;627-635.
24. 2+ current by activation of protein kinase C in rat ventricular myocytes. J. Physiol. 524:2000;807-820.
25. Hebb C. Motor innervation of the pulmonary blood vessel of mammals. Fishman A.P., Hecht H.H. The Pulmonary Circulation and Interstitial Space. 1969;195-222 University of Chicago Press, Chicago.
26. Hohlfeld J., Liebau S., Förstermann U. Pertussis toxin inhibits contractions but not endothelium-dependent relaxations of rabbit pulmonary artery in response to acetylcholine and other agonists. J. Pharmacol. Exp. Ther. 252:1990;260-264.
27. Hoover D.B., Neely D.A. Differentiation of muscarinic receptors mediating negative chronotropic and vasoconstrictor responses to acetylcholine in isolated rat hearts. J. Pharmacol. Exp. Ther. 282:1997;1337-1344.
28. Hulme E.C., Birdsall N.J.M., Buckley N.J. Muscarinic receptor subtypes. Annu. Rev. Pharmacol. Toxicol. 30:1990;633-673.
29. 2+ exchange in cells expressing NCX1. J. Biol. Chem. 271:1996;22391-22397.
30. Jaiswal N., Malik K.U. Methoctramine, a cardioselective antagonist: muscarinic receptor mediating prostaglandin synthesis in isolated rabbit heart. Eur. J. Pharmacol. 192:1991;63-70.
31. Jaiswal N., Lambrecht G., Mutschler E., Tacke R., Malik K.U. Pharmacological characterization of the vascular muscarinic receptors mediating relaxation and contraction in rabbit aorta. J. Pharmacol. Exp. Ther. 258:1991;842-850.
32. +-ATPase inhibitor constricts pulmonary arteries of spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 22:1993;S42-S46.
33. Janssens S.P., Thompson B.T., Spence C.R., Hales C.A. Functional and structural changes with hypoxia in the pulmonary circulation of spontaneously hypertensive rats. J. Appl. Physiol. 77:1994;1101-1107.
34. Kanagy N.L., Ansari M.N., Ghosh S., Webb R.C. Recycling and buffering of intracellular calcium in vascular smooth muscle from genetically hypertensive rats. J. Hypertens. 12:1994;1365-1372.
35. - currents by protein kinases A and C in the Xenopus oocyte. Biochem. Pharmacol. 59:2000;241-247.
36. + channel openers on aorta and pulmonary artery isolated from spontaneously hypertensive and Wistar-Kyoto rats. Eur. J. Pharmacol. 365:1999;241-251.
37. Lipp P., Pott L. Voltage dependence of sodium-calcium exchange current in guinea-pig atrial myocytes determined by means of an inhibitor. J. Physiol. 403:1988;355-366.
38. McCormack D.G., Mak J.C., Minette P., Barnes P.J. Muscarinic receptor subtypes mediating vasodilatation in the pulmonary artery. Eur. J. Pharmacol. 158:1988;293-297.
39. McMurty I.F., Petrun M.D., Tucker A., Reeves J.T. Pulmonary vascular reactivity in the spontaneously hypertensive rat. Blood Vessels. 16:1979;61-70.
40. + pump and sarcoplasmic reticulum in smooth muscle. Nature. 365:1993;657-660.
41. 3 muscarinic receptors in human pulmonary arteries. Br. J. Pharmacol. 119:1996;149-157.
42. + exchange isoform 1 activity in spontaneously hypertensive rats: lack of mutations within the coding region of NHE1. Biochim. Biophys. Acta. 1500:2000;169-180.
43. Ouchi Y., Share L., Crofton J.T., Iitake K., Brooks D.P. Sex difference in pressor responsiveness to vasopressin and baroreflex function in DOC-salt hypertensive rats. J. Hypertens. 6:1988;381-387.
44. Philipson K.D., Nicoll D.A. Molecular and kinetic aspects of sodium-calcium exchange. Int. Rev. Cyt. 137C:1993;199-227.
45. Phillips J.K., Vidovic M., Hill C.E. Variation in mRNA expression of alpha-adrenergic, neurokinin and muscarinic receptors amongst four arteries of the rat. J. Auton. Nerv. Syst. 62:1997;85-93.
46. + exchange to pH regulation in pulmonary artery smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 5:1991;586-591.
47. Reuter H., Blaustein M.P., Haeusler G. Na-Ca exchange and tension development in arterial smooth muscle. Philos. Trans. R. Soc. Lond. Ser. B. 265:1973;87-94.
48. Rosskopf D., Fromter E., Siffert W. Hypertensive sodium-proton exchanger phenotype persists in immortalized lymphoblasts from essential hypertensive patients. A cell culture model for human hypertension. J. Clin. Invest. 92:1993;2553-2559.
49. + exchange in pulmonary artery artery smooth muscle from spontaneously hypertensive and Wistar-Kyoto rats. Am. J. Physiol. 269:1995;L673-L680.
50. Tostes R.C., Storm D.S., Chi D.H., Webb R.C. Intracellular calcium stores and oscillatory contractions in arteries from genetically hypertensive rats. Hypertens. Res. 19:1996;103-111.
51. Toullec D., Pianetti P., Coste H., Bellevergue P., Grand-Perret T., Ajakane M., Baudet V., Biossin P., Boursier E., Loriolle F. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 266:1991;15771-15781.
52. Toyoda Y., Shima H., Sasajima H., Nishio I. Increased calcium sequestration by sarcoplasmic reticulum in small muscular arteries in young spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol. 22(1):1995;S223-S224.
53. Trippodo N.C., Frohlich E.D. Similarities of genetic (spontaneously) hypertension. Circ. Res. 48:1981;309-319.
54. + exchange kinetics and its activation by angiotensin II. Am. J. Physiol. 254:1988;C751-C758.
55. Walch L., Taisne C., Gascard J.P., Nashashibi N., Brink C., Norel X. Cholinesterase activity in human pulmonary arteries and veins. Br. J. Pharmacol. 121:1997;986-990.
56. 2+ exchanger in pulmonary artery smooth muscle cells. FASEB J. 14:2000;1731-1740.
57. Watts S.W. The development of enhanced arterial serotonergic hyperresponsiveness in mineralocorticoid hypertension. J. Hypertens. 16:1998;811-822.
58. Wilson E.B. The inhibition and reactivation of acetylcholinesterase. Ann. N.Y. Acad. Sci. 135:1966;177-183.
59. Wood P. The Eisenmenger syndrome: pulmonary hypertension with reversed central shunt. Br. Med. J. 2:1958;701-709.
60. Zhao Y., Rhoades R.A., Packer C.S. Hypoxia-induced pulmonary arterial contraction appears to be dependent on myosin light chain phosphorylation. Am. J. Physiol. 271:1996;L768-L774.